Flu shots for the United States' 2023-2024 influenza season are now available. But when's the best time to get the vaccine, and who should get one?
Here's a rundown of what you need to know about this season's flu vaccines.
Related: Could we ever eradicate the flu?
These exceptions apply to people with severe, life-threatening allergies to specific vaccine ingredients. These potentially allergy-triggering ingredients include gelatin, which is used as a stabilizer in some vaccines, and certain antibiotics, which prevent bacterial contamination during vaccine manufacturing but can linger in very small quantities in some shots post-production, according to the Children's Hospital of Philadelphia.
People who have had a severe allergic reaction to a flu vaccine should not get the same type of vaccine again and should consult a doctor about whether to get a different shot, the CDC says. People with a history of Guillain-Barré Syndrome, a rare paralyzing condition in which the immune system attacks the nerves, should also consult a doctor before getting a flu shot.
But everyone else can assume they should get a shot. Flu shots are especially important for people who are older than 65, younger than 2, pregnant, or have very recently given birth, the CDC states. Note that some children ages 6 months to 8 years are recommended to get two doses of vaccine.
Related: The flu shot isn't that effective. Here's why you should still get it.
Speak to a doctor, pharmacist or other health care professional if you have questions about which flu shot is best for you.
Standard-dose, inactivated flu shots: Inactivated flu shots contain influenza viruses that have been "killed" so they can no longer infect cells. They are approved for use in people ages 6 months and older.
Recombinant flu shots: Recombinant flu shots are made using "recombinant technology," which involves using flu virus genetic material to make a protein found on the virus' surface — hemagglutinin (HA). There is one recombinant vaccine available called Flublok Quadrivalent, and it's approved for use in people ages 18 and older. It's one of three vaccine options especially recommended to people 65 years and older.
Nasal spray: The one vaccine that's available as a nasal spray is called FluMist Quadrivalent. It's a live attenuated vaccine, meaning it contains weakened flu viruses that can't cause disease but have not been "killed," like the viruses in inactivated shots. This vaccine is approved for most people ages 2 to 49, but it's not approved for people who are pregnant, have weakened immune systems or have certain other conditions.
High-dose and adjuvanted flu shots: One high-dose flu vaccine and one adjuvanted vaccine, which contains an added ingredient to rev up the immune system, are approved for use in people 65 and older. Along with the recombinant shot, these vaccines are especially recommended for older people because they're more protective in this age group than the standard-dose vaccines. The high-dose shot is called Fluzone High-Dose Quadrivalent and the adjuvanted vaccine is called Fluad Quadrivalent.
RELATED STORIES
—The worst epidemics and pandemics in history
—2 types of flu viruses may have gone extinct
—Why is the flu shot less effective than other vaccines?
"Egg allergy alone necessitates no additional safety measures for influenza vaccination beyond those recommended for any recipient of any vaccine, regardless of severity of previous reaction to egg," the committee advised. All vaccines should be given in settings where allergic reactions can be recognized and treated quickly, according to the new guidance.
Vaccine makers decide which flu strains to include in shots for the upcoming season by checking which strains are circulating elsewhere in the world. The Northern Hemisphere and Southern Hemisphere flu seasons happen at different times, so flu virus samples collected in one hemisphere can provide the other clues as to what's to come.
On Sept. 8, the CDC released data on how well the Southern Hemisphere's flu shots performed during their recent season. Data from Argentina, Brazil, Chile, Paraguay and Uruguay showed the shots reduced the risk of flu-related hospitalizations by 52%, overall, and were slightly more protective against the predominant A(H1N1) viruses, specifically. Flu shots available in the U.S. might offer similar protection if these viruses dominate in the Northern Hemisphere's flu season, as well.
This article is for informational purposes only and is not meant to offer medical advice.
Editor's note: This article was updated on Sept. 8, 2023 to add new information about the Southern Hemisphere's flu shots. It was first published on Sept. 3.